Printer Friendly

CARDIOPULMONICS REPORTS SECOND QUARTER 1993 RESULTS

 SALT LAKE CITY, July 26 /PRNewswire/ -- CardioPulmonics(R) Inc. (NASDAQ-NMS: CRDS) today reported results for its second quarter and six months ended June 30, 1993.
 For the quarter ended June 30, 1993, CardioPulmonics reported a net loss of $1,391,322, or $.16 per share. This compares to a net loss of $1,488,980, or $.18 per share, for the same quarter ended June 30, 1992.
 The net loss for the quarter ended June 30, 1993, also compares to a net loss of $2,733,739 reported for the quarter ended March 31, 1993. The reduction in net loss of $1,342,417, when compared to first quarter results, includes the effect of the company's reduction in force and related expenses realized during the first quarter and other cash conservation measures.
 The company's net loss for the six months ended June 30, 1993, was $4,125,061, or $.49 per share, compared to $2,515,785, or $.32 per share, for the same period in 1992.
 The company's balance sheet reflects $17,698,800 in cash, cash equivalents and cash investments as of June 30, 1993.
 CardioPulmonics Inc. manufactures the IVOX(R) device (Intravascular Oxygenator) under an IDE (Investigational Device Exemption) from the FDA (United States Food and Drug Administration).
 -0- 7/26/93
 /CONTACT: William S. Barth of CardioPulmonics, 801-350-3600/
 (CRDS)


CO: CardioPulmonics Inc. ST: Utah IN: MTC SU: ERN

LM-BP -- LA027 -- 5846 07/26/93 16:01 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jul 26, 1993
Words:241
Previous Article:COMPUWARE CORPORATION REPORTS FIRST-QUARTER RESULTS
Next Article:CAMBRIDGE ENVIRONMENTAL SYSTEMS INC. ANNOUNCE APPOINTMENTS
Topics:


Related Articles
CARDIOPULMONICS REPORTS 1992 THIRD QUARTER RESULTS
CARDIOPULMONICS ANNOUNCES APPOINTMENT OF NEW PRESIDENT AND CEO
CARDIOPULMONICS REPORTS THIRD QUARTER 1993 RESULTS
CARDIOPULMONICS, INC. SIGNS DEFINITIVE AGREEMENT TO ACQUIRE INNERDYNE MEDICAL, INC.
CARDIOPULMONICS REPORTS 1993 RESULTS
CARDIOPULMONICS INC. FILES REGISTRATION STATEMENT ON FORM S-4
CARDIOPULMONICS INC. SIGNS AGREEMENT TO LICENSE COATING TECHNOLOGY TO SENKO MEDICAL INSTRUMENT MANUFACTURING CO. LTD., TOKYO
CARDIOPULMONICS REPORTS FIRST QUARTER 1994 RESULTS AND CONFIRMS CHANGE IN STOCK TRADING SYMBOL TO 'IDYN'
INNERDYNE INC. REPORTS SECOND QUARTER 1994 RESULTS
INNERDYNE INC. REPORTS THIRD QUARTER 1994 RESULTS

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters